ProductsPricingFree Market DashboardMarket News FeedScannerChartsHeatmapMarket SectorsTrack RecordMAD AcademyMCP Connector

Ligand Pharmaceuticals Inc. (LGND)

Nasdaq · Common stock · Pharmaceutical Preparations

$313.52+7.12 (+2.32%)

As of Oct 21, 3:20 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.

Follow LGND in real time

Real-time quotes, Pro Charting, the scanner and the alert feed on LGND and every other US listing.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Or open the free LGND chart →

LGND at a glance

Key statistics

$6.11B

Market capitalization

Previous close
$306.40
Open
$309.83
Day range
$303.87 – $313.53
Volume
109.1K
Average volume (30 sessions)
252.0K
Shares outstanding
19.94M
Price / earnings
31.0
Earnings per share
$9.89
Price / book
6.3
Price / sales
21.0
Beta (1 year, vs SPY)
0.78

Where the price sits in its year

52-week range

91% of the range

Below the 52-week high
-4.0%
Above the 52-week low
+78.2%

Completed sessions through Oct 20, 2026

Technical snapshot

Above its 50-day and 200-day averages

20-day average
$302.13+1.4%
50-day average
$292.75+4.7%
200-day average
$248.06+23.5%
RSI (14)56.3

Between the conventional 30 and 70 bands.

+0.9%

1 week

+5.6%

1 month

+0.7%

3 months

+62.1%

Year to date

+68.7%

1 year

Price change over each window, from completed sessions. Past performance does not indicate future results.

Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.

The member platform, in real time

What members do with LGND

Every plan

LGND on Pro Charting

Every intraday interval in real time, the drawing kit and the full set of technical studies on LGND.

See the plans →

Every plan

Screen names like LGND

The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.

See the plans →

Analysis Tools Only

Set a price line on LGND

Put LGND on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.

See the plans →

Stock Alerts + Tools

Open alerts on LGND

See whether there is an open premium alert on LGND, with its entry, stop and exit, each one reviewed by an analyst before it is sent.

See the plans →

From the public news wire

LGND headlines

Market news →

SEC Form 4, most recent first

Insider filings

How to read these →

  • Reardon Andrew

    −404

    CLO & Secretary · Open-market sale

    $123.70K · Oct 2, 2026

  • Reardon Andrew

    −1.5K

    CLO & Secretary · Open-market sale

    $467.43K · Oct 2, 2026

  • Reardon Andrew

    −17

    CLO & Secretary · Open-market sale

    $5.23K · Oct 2, 2026

  • Reardon Andrew

    −340

    CLO & Secretary · Option exercise

    · Oct 2, 2026

  • Reardon Andrew

    −235

    CLO & Secretary · Open-market sale

    $72.19K · Oct 2, 2026

  • Reardon Andrew

    −833

    CLO & Secretary · Open-market sale

    $251.99K · Oct 2, 2026

  • Reardon Andrew

    −2.0K

    CLO & Secretary · Open-market sale

    $599.80K · Oct 2, 2026

  • Reardon Andrew

    +340

    CLO & Secretary · Option exercise

    $17.77K · Oct 2, 2026

About Ligand Pharmaceuticals Inc.

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Exchange
Nasdaq
Security
Common stock
Industry
Pharmaceutical Preparations
Headquarters
San Diego, CA
Employees
47
Listed since
Nov 25, 1994
Website
ligand.com
Educational content only. MadStockAlerts provides market commentary, research, and educational content. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security. Trading and investing involve substantial risk, including loss of capital. See the Risk Disclosure and Customer Agreement.

Pick the desk that fits how you trade

Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.